Related Experiment Videos
Genes, immunity, and senescence: looking for a link
Immunological Reviews
|February 26, 1998
Summary
Boosting immune responses in mice genetically selected for high immunity extends lifespan and reduces cancer. This highlights the critical link between a robust immune system and healthy aging, suggesting potential cytokine therapies for age-related immune decline.
Area of Science:
- Immunology
- Gerontology
- Genetics
Background:
- Aging is regulated by specific genes, with immune system decline being a hallmark.
- Mice bred for high immune responses show increased longevity and reduced lymphoma rates.
- Age-related immune changes include T-cell alterations, B-cell defects, and reduced natural killer (NK) cell activity.
Purpose of the Study:
- To investigate the relationship between immune system function and the aging process.
- To explore the impact of genetic selection for immune response on lifespan and healthspan.
- To identify potential therapeutic targets for age-related immune dysfunction.
Main Methods:
- Comparative analysis of genetically selected mouse lines with differing immune responses.
- Assessment of immune cell populations (T cells, B cells, NK cells) and their functions in aging mice.
- In vitro analysis of cytokine production (IL-2, IFN-gamma, IL-4) by spleen cells from aged mice.
Main Results:
- High immune response selection correlated with extended lifespan and lower lymphoma incidence.
- Significant age-related changes observed in T-cell populations, B-cell function, and NK cell activity.
- Cytokine production (IL-2, IFN-gamma, IL-4) altered with age, but responsive to recombinant cytokine treatment in vitro.
Conclusions:
- Immune system health is a key determinant of aging and longevity.
- Age-related immune decline involves specific cellular and molecular defects.
- Cytokine-based interventions show promise for mitigating age-related immune disorders and improving quality of life in old age.